Drugs Home > Brentuximab Vendotin

Were you looking for more information about Brentuximab Vedotin? Brentuximab vendotin is a common misspelling of brentuximab vedotin.
 
Brentuximab vedotin (Adcetris™) is a chemotherapy drug prescribed for the treatment of certain types of lymphoma in adults age 18 and older. It is specifically approved for treating Hodgkin's lymphoma and systemic anaplastic large cell lymphoma when the cancer has not adequately responded to other treatment.
 
This medication is given as an intravenous (IV) injection once every three weeks. Nausea, fatigue, and diarrhea are among the possible side effects.
 
(Click Brentuximab Vedotin for more information on what this chemotherapy medicine is used for, how it works, and what your healthcare provider needs to know before prescribing this drug. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.